Finance

Beta
Lists
PHAR:NASDAQ
Pharming Group NV - ADR
US$ १३.७७
+०.८४%
(+०.११) 1D
जुलाई २, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAR...
Open
US$ १३.८५
High
US$ १३.९७
Low
US$ १३.७२
Mkt. cap
८८.६४ करोड
Avg. vol.
९.०२ हजार
Volume
४.५८ हजार
52-wk high
US$ २१.३०
52-wk low
US$ ९.२८
Beta
-०.०३
Shares outstanding
७.०६ करोड
No. of employees
४०७
Open
US$ १३.८५
High
US$ १३.९७
Low
US$ १३.७२
Mkt. cap
८८.६४ करोड
Avg. vol.
९.०२ हजार
Volume
४.५८ हजार
52-wk high
US$ २१.३०
52-wk low
US$ ९.२८
Beta
-०.०३
Shares outstanding
७.०६ करोड
No. of employees
४०७
News stories
From sources across the web
About Pharming Group NV - ADR
CEO-
Employees४०७
Founded१९८८
Headquarters-
Sector-
Websitepharming.com
Analyst ratings
Based on 3 analysts giving stock ratings to PHAR in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PHAR in the last 3 months.
Highest
Current US$ १३.७७
US$ ४०.०० (+१९०.४९%)
Average
US$ ३८.०० (+१७५.९६%)
Lowest
US$ ३७.०० (+१६८.७०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Whitney Ijem
Canaccord Genuity
Buy
Maintained
US$ ३७.००
+१६८.७%
06/22/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$ ३७.००
+१६८.७%
06/04/2026
Jeff Jones
Oppenheimer
Buy
Maintained
US$ ४०.००
+१९०.५%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
९.३२ करोड
९.७३ करोड
१०.६५ करोड
७.२४ करोड
Cost of goods sold
८९.७२ लाख
७०.७१ लाख
२.११ करोड
६६.४४ लाख
Cost of revenue
८९.७२ लाख
७०.७१ लाख
२.११ करोड
६६.४४ लाख
Research and development expenses
२.५८ करोड
२.१३ करोड
३.२० करोड
२.५६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५.७३ करोड
४.३१ करोड
५.०७ करोड
४.५५ करोड
Operating expense
८.१२ करोड
६.४३ करोड
८.२४ करोड
७.०७ करोड
Total operating expenses
९.०२ करोड
७.१४ करोड
१०.३५ करोड
७.७४ करोड
Operating income
३०.४९ लाख
२.५९ करोड
३०.२९ लाख
-४९.११ लाख
Other non operating income
-७.३८ लाख
१८.८२ लाख
४.०३ लाख
-
EBT including unusual items
७०.७९ लाख
१.२८ करोड
४८.०० लाख
-४७.५४ लाख
EBT excluding unusual items
-७.२१ लाख
२.२९ करोड
१६.१४ लाख
-४७.५४ लाख
Income tax expense
२५.२९ लाख
५२.०९ लाख
-५.२८ लाख
४.५९ लाख
Effective tax rate
३५.७३%
४०.८३%
-११.००%
-९.६५%
Other operating expenses
-१८.४९ लाख
-७१.०० हजार
-३.४८ लाख
-३.७७ लाख
Net income
४६.९४ लाख
७५.४८ लाख
५३.२८ लाख
-५२.१३ लाख
Net profit margin
५.०४%
७.७६%
५.००%
-७.२०%
Earnings per share
०.०१
०.०१
०.०१
-०.०७
Interest and investment income
१२.६३ लाख
-
४५.०५ लाख
३२.३७ लाख
Interest expense
-४.०० हजार
-९२.०९ लाख
-
-२६.९५ लाख
Net interest expenses
१२.५९ लाख
-९२.०९ लाख
४५.०५ लाख
५.४२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
४२.७६ लाख
३.०१ करोड
६२.३५ लाख
-१७.९५ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer